[Systemic chemotherapy and breast cancer].

  title={[Systemic chemotherapy and breast cancer].},
  author={Jo{\"e}lle Collignon and Andr{\'e}e Rorive and Marie F. Martin and Catherine Andr{\'e} and Sylvie Maweja and Eric Lifrange and P M Coucke and Guy H M Jerusalem},
  journal={Revue medicale de Liege},
  volume={66 5-6},
Breast cancer mortality is decreasing, partly due to better adjuvant treatments with new drugs and new schedules. In Belgium, the overall survival is 76%. Chemotherapy is still an important treatment option. We need to better select patients who really will benefit from treatment in order to decrease toxicity and improve long term outcome.Targeting the specific population is now a priority. Prognostic and predictive factors will enable us to better define the sub-population of patients most… CONTINUE READING